输尿管支架引流不增加膀胱切除术后上尿路尿路上皮癌风险
该回顾性队列研究纳入2000至2015年间1049例因尿路上皮癌行根治性膀胱切除术且术前无上尿路尿路上皮癌诊断的患者,比较术前肾积水不同引流方式与术后上尿路尿路上皮癌及输尿管并发症风险。结果显示,肾造瘘管引流(HR 4.10)和输尿管支架(HR 2.35)均与术后上尿路尿路上皮癌相关,但输尿管支架不增加上尿路尿路上皮癌或输尿管并发症风险。
要点
- 术前肾积水与根治性膀胱切除术后上尿路尿路上皮癌发生相关。
- 肾造瘘管引流和输尿管支架均与术后上尿路尿路上皮癌相关。
- 输尿管支架不增加上尿路尿路上皮癌或输尿管并发症风险。
核心结论
- 术前肾积水与根治性膀胱切除术后上尿路尿路上皮癌相关,但输尿管支架置入相较于肾造瘘管置入不增加上尿路尿路上皮癌或输尿管并发症风险。
- 术前肾积水引流方式的选择不应基于对上尿路尿路上皮癌风险的担忧。
研究设计与样本
- 回顾性队列研究,纳入2000至2015年间在本机构因尿路上皮癌行根治性膀胱切除术且术前无上尿路尿路上皮癌诊断的患者,共1049例。
- 患者分为4组:无肾积水组(75%,N=787)、肾积水未行上尿路引流组(13%,N=132)、肾造瘘管引流组(3%,N=36)、输尿管支架引流组(9%,N=94)。
- 采用Kaplan-Meier分析和多变量Cox比例风险模型比较术后上尿路尿路上皮癌和输尿管并发症发生率。
主要发现
- 中位术后随访4.3年。
- 输尿管肠吻合口并发症发生率在不同引流方式间无差异。
临床怎么用
- 对于根治性膀胱切除术前存在肾积水的患者,选择输尿管支架或肾造瘘管引流时,无需因担心上尿路尿路上皮癌风险而影响决策。
- 术前肾积水患者术后应关注上尿路尿路上皮癌的发生风险。
局限性
- 回顾性研究设计。
- 样本来自单中心。
- 引流组样本量较小(肾造瘘管组N=36,输尿管支架组N=94)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To guide management of preoperative hydronephrosis prior to radical cystectomy (RC), we compared post-RC risks of upper tract urothelial carcinoma (UTUC) and ureteroenteric anastomotic complications between ureteral stent and percutaneous nephrostomy tube drainage. METHODS: Patients who underwent RC for urothelial carcinoma without a prior diagnosis of UTUC at our institution between 2000 and 2015 were included and divided into 4 patient groups: (1) no hydronephrosis (75%, N = 787); (2) hydronephrosis without preoperative upper tract drainage (13%, N = 132); (3) hydronephrosis treated with nephrostomy tube (3%, N = 36); (4) hydronephrosis treated with ureteral stent (9%, N = 94). The incidence of post-RC UTUC and ureteral complications was compared using Kaplan-Meier analyses and multivariable Cox proportional hazard modeling. RESULTS: We identified a total of 1049 patients who underwent RC (median postoperative follow-up 4.3 years). Five-year post-RC UTUC incidence was 6.6%, 10.2%, 17%, 18.7% for groups 1-4, respectively (P= .13). On multivariable analysis, nephrostomy tube drainage (hazard ratio [HR] 4.10, P = .02) and preoperative ureteral stenting (HR 2.35, P = .04) were both associated with UTUC after RC, but ureteral stenting did not have a significantly higher association with UTUC than nephrostomy tube drainage. Severe hydronephrosis was also associated with development of UTUC (HR 4.03, P = .02). The incidence of ureteroenteric anastomotic complications did not vary by drainage modality. CONCLUSION: Preoperative hydronephrosis was associated with UTUC after RC, but ureteral stent placement did not increase the risk of UTUC or ureteral complications relative to nephrostomy tube placement. The choice of hydronephrosis drainage pre-RC should not be guided by concern for UTUC risk.
引用
- Miest TS, Sharma V, Boeri L, et al. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications? Urology. 2020. PMID: 32763318. doi:10.1016/j.urology.2020.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。